Related Experiment Video
Updated: May 1, 2026

In Vivo Biosensor Tracks Non-apoptotic Caspase Activity in Drosophila
Published on: November 27, 2016
The DCC gene product induces apoptosis by a mechanism requiring receptor proteolysis
P Mehlen1, S Rabizadeh, S J Snipas
1Program on Aging, The Burnham Institute, La Jolla, California 92037, USA.
Abstract:
The development of colonic carcinoma is associated with the mutation of a specific set of genes. One of these, DCC (deleted in colorectal cancer), is a candidate tumour-suppressor gene, and encodes a receptor for netrin-1, a molecule involved in axon guidance. Loss of DCC expression in tumours is not restricted to colon carcinoma, and, although there is no increase in the frequency of tumour formation in DCC hemizygous mice, reestablishment of DCC expression suppresses tumorigenicity. However, the mechanism of action of DCC is unknown. Here we show that DCC induces apoptosis in the absence of ligand binding, but blocks apoptosis when engaged by netrin-1. Furthermore, DCC is a caspase substrate, and mutation of the site at which caspase-3 cleaves DCC suppresses the pro-apoptotic effect of DCC completely. These results indicate that DCC may function as a tumour-suppressor protein by inducing apoptosis in settings in which ligand is unavailable (for example, during metastasis or tumour growth beyond local blood supply) through functional caspase cascades by a mechanism that requires cleavage of DCC at Asp 1,290.
Insights
The deleted in colorectal cancer (DCC) gene suppresses tumors by inducing apoptosis when its ligand, netrin-1, is absent. DCC cleavage by caspase-3 is essential for this tumor-suppressive function.
Area of Science:
- Molecular biology
- Cancer research
- Cell signaling
Background:
- Colorectal cancer development involves gene mutations, including the candidate tumor suppressor DCC.
- DCC encodes the netrin-1 receptor, crucial for axon guidance.
- Loss of DCC expression correlates with tumorigenicity, but its mechanism remains unclear.
Purpose of the Study:
- To elucidate the mechanism by which DCC suppresses tumor formation.
- To investigate the role of netrin-1 binding and caspase cleavage in DCC function.
Main Methods:
- Investigated DCC's effect on apoptosis with and without netrin-1.
- Identified DCC as a caspase substrate.
- Mutated the caspase-3 cleavage site on DCC to assess its impact on apoptosis.
Main Results:
- DCC induces apoptosis independently of netrin-1 binding.
- Netrin-1 binding to DCC inhibits apoptosis.
- Cleavage of DCC by caspase-3 is required for its pro-apoptotic activity, specifically at Asp 1,290.
Conclusions:
- DCC functions as a tumor suppressor by promoting apoptosis when netrin-1 is unavailable.
- This pro-apoptotic function is mediated by caspase cascades and requires DCC cleavage at Asp 1,290.
- DCC's mechanism involves ligand-independent apoptosis induction via caspase-mediated cleavage, crucial for tumor suppression.
Related Concept Videos
Apoptosis
Caspases
The Extrinsic Apoptotic Pathway
The Intrinsic Apoptotic Pathway
Phagocytosis of Apoptotic Cells
Normal cells contain receptors that prevent them from being recognized...
Cellular Injury V: Apoptosis and Autophagy

